[
    "idine-1-carboxylic acid tert-butyl esterStep 1: 3-(4-chloromethyl-thiazol-2-yl)-azetidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00168\" path=\"US08975258-20150310-C00168.TIF\" file=\"https://surechembl.org/api/assets/attachment/294857075/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00168.TIF\"/></p>To a solution of 3-Thiocarbamoyl-azetidine-1-carboxylic acid tert-butyl ester (0.800 g, 3.7 mmol) in acetone (15 mL) was added 1,3-dichloroacetone (0.611 g, 4.81 mmol), MgSO<sub>4 </sub>(0.67 g, 5.6 mmol) and MgCO<sub>3 </sub>(3.12 g, 3.7 mmol). The mixture was heated under reflux overnight, cooled and filtered through celite. The solvent was removed in vacuo and the residue was redissolved with EtOAc (20 mL). The resulting solution was washed successively with 5% NaHSO<sub>3</sub>, saturated NaHCO<sub>3</sub>, and brine. After drying (Na<sub>2</sub>SO<sub>4</sub>), the solvent was removed to afford the desired product which was used without further purification.</p>Step 2: 3-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-azetidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00169\" path=\"US08975258-20150310-C00169.TIF\" file=\"https://surechembl.org/api/assets/attachment/294856711/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00169.TIF\"/></p>A mixture of 3-(4-chloromethyl-thiazol-2-yl)-azetidine-1-carboxylic acid tert-butyl ester (From Step 1) (386 mg, 1.34 mmol), 4-tetrazol-1-yl-phenol (217 mg, 1.34 mmol), Cs<sub>2</sub>CO<sub>3 </sub>(655 mg, 2.01 mmol) and KI (22 mg, 0.13 mmol) in acetonitrile (5 mL) was heated under reflux for 4 hours. After cooling, the solid was filtered through a pad of celite. The filtrate was concentrated in vacuo. The residue was purified on silica gel (EtOAc-hexanes, 1:1) to afford the desired product. <sup>1</sup>H NMR (CDCl<sub>3</sub>): \u03b4 8.92 (1H, s), 7.61 (2H, d), 7.32 (1H, s), 7.19 (2H, d), 5.25 (2H, s), 4.39 (2H, m), 4.18 (2H, m), 4.14 (1H, m), 1.46 (9H, s).</p>Example 1023-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-pyrrolidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00170\" path=\"US08975258-20150310-C00170.TIF\" file=\"https://surechembl.org/api/assets/attachment/294856695/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00170.TIF\"/></p>Step 1: 3-(4-Chloromethyl-thiazol-2-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00171\" path=\"US08975258-20150310-C00171.TIF\" file=\"https://surechembl.org/api/assets/attachment/294857218/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00171.TIF\"/></p>To a solution of 3-thiocarbamoyl-pyrrolidine-1-carboxylic acid tert-butyl ester (1.06 g, 4.60 mmol) in acetone (25 mL) was added 1,3-dichloroacetone (0.76 g, 5.98 mmol), MgSO<sub>4 </sub>(0.83 g, 6.1 mmol) and MgCO<sub>3 </sub>(3.87 g, 4.6 mmol). The mixture was heated under reflux overnight, cooled and filtered through celite. The solvent was removed in vacuo and the residue was redissolved with EtOAc (20 mL). The resulting solution was washed successively with 5% NaHSO<sub>3</sub>, saturated NaHCO<sub>3</sub>, and brine. After drying (Na<sub>2</sub>SO<sub>4</sub>), the solvent was removed to afford the desired product which was used without further purification.</p>Step 2: 3-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-pyrrolidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00172\" path=\"US08975258-20150310-C00172.TIF\" file=\"https://surechembl.org/api/assets/attachment/294857194/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00172.TIF\"/></p>A mixture of 3-(4-Chloromethyl-thiazol-2-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester (From Step 1) (775 mg, 2.56 mmol), 4-tetrazol-1-yl-phenol (415 mg, 2.56 mmol), CsCO<sub>3 </sub>(1.25 mg, 3.84 mmol) and KI (44 mg, 0.26 mmol) in acetonitrile (20 mL) was heated under reflux overnight. After cooling, the solid was filtered through a pad of celite. The filtrate was concentrated in vacuo. The residue was purified on silica gel (EtOAc-hexanes, 1:1) to afford the desired product. <sup>1</sup>H NMR (CDCl<sub>3</sub>): \u03b4 8.92 (1H, s), 7.63 (2H, d), 7.27 (1H, s), 7.17 (2H, d), 5.24 (2H, s), 3.87 (1H, m), 3.79 (1H, m), 3.65 (2H, m), 3.45 (1H, m), 2.40 (1H, m), 2.23 (1H, m), 1.47 (9H, s).</p>Example 1035-Ethyl-2-{3-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-pyrrolidin-1-yl}-pyrimidineStep 1: 1-[4-(2-Pyrrolidin-3-yl-thiazol-4-ylmethoxy)-phenyl]-1H-tetrazole<img id=\"EMI-C00173\" path=\"US08975258-20150310-C00173.TIF\" file=\"https://surechembl.org/api/assets/attachment/294856795/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00173.TIF\"/></p>A solution of 3-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-pyrrolidine-1-carboxylic acid tert-butyl ester (from Example 102) (411 mg, 0.959 mmol) in dichloromethane (10 mL) and methanol (2 mL) were treated with 1 mL of 4N HCl in dioxane. The resulting solution was stirred at room temperature for 30 minutes. The solvents were removed in vacuo to afford the desired product as an HCl salt.</p>Step 2: 5-Ethyl-2-{3-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-pyrrolidin-1-yl}-pyrimidine<img id=\"EMI-C00174\" path=\"US08975258-20150310-C00174.TIF\" file=\"https://surechembl.org/api/assets/attachment/294856992/US/20150310/B2/000008/97/52/58/US0897",
    "97/52/58/US08975258-20150310-C00175.TIF\"/></p>Step 1: 3-(4-Chloromethyl-thiazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00176\" path=\"US08975258-20150310-C00176.TIF\" file=\"https://surechembl.org/api/assets/attachment/294856626/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00176.TIF\"/></p>To a solution of 3-Thiocarbamoyl-piperidine-1-carboxylic acid tert-butyl ester (2.2 g, 9.02 mmol) in acetone (45 mL) was added 1,3-dichloroacetone (1.49 g, 11.7 mmol), MgSO<sub>4 </sub>(1.63 g, 13.5 mmol) and MgCO<sub>3 </sub>(0.76 g, 9.02 mmol). The mixture was heated under reflux overnight, cooled and filtered through celite. The solvent was removed in vacuo and the residue was redissolved with EtOAc (20 mL). The resulting solution was washed successively with 5% NaHSO<sub>3</sub>, saturated NaHCO<sub>3</sub>, and brine. After drying (Na<sub>2</sub>SO<sub>4</sub>), the solvent was removed to afford the desired product which was used without further purification.</p>Step 2: 3-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester<img id=\"EMI-C00177\" path=\"US08975258-20150310-C00177.TIF\" file=\"https://surechembl.org/api/assets/attachment/294857202/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00177.TIF\"/></p>A mixture of 3-(4-Chloromethyl-thiazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester (From Step 1) (300 mg, 0.946 mmol), 4-tetrazol-1-yl-phenol (155 mg, 0.946 mmol), CsCO<sub>3 </sub>(467 mg, 1.42 mmol) and KI (16 mg, 0.095 mmol) in acetonitrile (10 mL) was heated under reflux for 4 hours. After cooling, the solid was filtered through a pad of celite. The filtrate was concentrated in vacuo. The residue was purified on silica gel (EtOAc-hexanes, 1:1) to afford the desired product. <sup>1</sup>H NMR (CDCl<sub>3</sub>): \u03b4 8.91 (1H, s), 7.63 (2H, d), 7.26 (1H, s), 7.17 (2H, d), 5.24 (2H, s), 4.30 (1H, br), 4.02 (1H, m), 3.20 (1H, m), 3.10 (1H, br), 2.88 (1H, t), 2.21 (1H, m), 1.77 (2H, m), 1.61 (1H, m), 1.47 (9H, s).</p>Example 1055-Ethyl-2-{3-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineStep 1: 3-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidine<img id=\"EMI-C00178\" path=\"US08975258-20150310-C00178.TIF\" file=\"https://surechembl.org/api/assets/attachment/294856550/US/20150310/B2/000008/97/52/58/US08975258-20150310-C00178.TIF\"/></p>A solution of 3-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester (500 mg, 1.13 mmol) in dichloromethane (10 mL) and methanol (2 mL) were treated with 2 mL of 4N HCl in dioxane. The resulting solution was stirred at room temperature for 30 minutes. The solvents were removed in vacuo to afford the desired product as an HCl salt.</p>Step 2: 5-Ethyl-2-{3-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine<img id=\"EMI-C00179\" path=\"US08975258-20150310-C00179.TIF\" file=\"https://surechembl.org/api/assets/attachment/294857306/US/20150310/B2/000008/97/52/58/"
]